EHS
EHS

Use of complementary medicine linked to greater risk for cancer death

The use of complementary medicine for the treatment of lung, breast, prostate or colorectal cancer appeared associated with refusal of conventional cancer treatment and almost double the risk for death compared with adherence to conventional cancer treatment, according to results of a retrospective, observational study.
The higher mortality risk associated with complementary medicine may be driven by the higher rates of treatment refusal than by the treatments themselves.
“The use of complementary and alternative medicine is estimated to be a multibillion dollar industry in the United States,”
EHS
Back to top button